| Literature DB >> 27184078 |
Sanjay Kumar1, Christopher C Pan1, Nirav Shah1, Sarah E Wheeler1, Kari R Hoyt1, Nadine Hempel2, Karthikeyan Mythreye3, Nam Y Lee4.
Abstract
Smads are nuclear-shuttling transcriptional mediators of transforming growth factor-β (TGF-β) signaling. Although their essential nuclear roles in gene regulation during development and carcinogenesis are well established, whether they have important cytoplasmic functions remains unclear. Here we report that Smad2 is a critical determinant of mitochondrial dynamics. We identified mitofusin2 (MFN2) and Rab and Ras Interactor 1 (RIN1) as new Smad2 binding partners required for mitochondrial fusion. Unlike TGF-β-induced Smad2/3 transcriptional responses underlying mitochondrial fragmentation and apoptosis, inactive cytoplasmic Smad2 rapidly promotes mitochondrial fusion by recruiting RIN1 into a complex with MFN2. We demonstrate that Smad2 is a key scaffold, allowing RIN1 to act as a GTP exchange factor for MFN2-GTPase activation to promote mitochondrial ATP synthesis and suppress superoxide production. These results reveal functional implications between Smads and mitochondrial dysfunction in cancer and metabolic and neurodegenerative disorders.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27184078 PMCID: PMC4877164 DOI: 10.1016/j.molcel.2016.04.010
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970